PDSB offering history
Every offering-related filing in PDS Biotechnology Corp’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 769 filings back to Sep 16, 2009.
| Date | Filing | What it means | |
|---|---|---|---|
| Jul 21, 2026 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jul 21, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 10, 2026 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 15, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 15, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 1, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 28, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 24, 2026 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Nov 12, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 29, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 10, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 27, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 2, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 28, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 13, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 3, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 2, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 24, 2022 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Aug 24, 2022 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 16, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 14, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 12, 2020 | 424B2 → | EXECUTED | Prospectus supplement priced — shares or notes (large filers: often a bond deal) |
| Aug 10, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 31, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 22, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Feb 12, 2020 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Feb 11, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Feb 11, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 31, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jan 17, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jan 17, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Dec 17, 2019 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Aug 29, 2019 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 28, 2019 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 20, 2019 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Aug 2, 2019 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jul 30, 2019 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 15, 2019 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 19, 2017 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 2, 2016 | 424B2 → | EXECUTED | Prospectus supplement priced — shares or notes (large filers: often a bond deal) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
PDSB offering FAQ
When did PDSB last execute an offering?
Per SEC filings, PDS Biotechnology Corp's most recent priced offering document is a 424B4 filed 2026-07-21. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did PDSB last announce or register an offering?
The most recent registration is a S-3 filed 2026-07-10. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.